Compugen (CGEN) News Today → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CGEN Stock Alerts $1.97 -0.14 (-6.64%) (As of 09:34 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 7:00 AM | prnewswire.comCompugen Reports First Quarter 2024 ResultsMay 17 at 2:20 PM | msn.comCompugen Q1 2024 Earnings PreviewMay 16, 2024 | prnewswire.comCompugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic PotentialMay 15, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Appoints David Silberman as Chief Financial OfficerMay 15, 2024 | marketwatch.comCompugen Names David Silberman Chief Financial OfficerMay 15, 2024 | prnewswire.comCompugen Appoints David Silberman as Chief Financial OfficerMay 15, 2024 | americanbankingnews.comCompugen (NASDAQ:CGEN) Downgraded by StockNews.comMay 14, 2024 | stocknews.com3 Biotech Stocks to Monitor for May MovesMay 13, 2024 | americanbankingnews.comCompugen (CGEN) to Release Earnings on MondayMay 10, 2024 | americanbankingnews.comCompugen (NASDAQ:CGEN) Stock Passes Above 200-Day Moving Average of $1.78May 6, 2024 | prnewswire.comCompugen to Release First Quarter 2024 Results on Monday, May 20, 2024April 29, 2024 | finance.yahoo.comWe're Not Worried About Compugen's (NASDAQ:CGEN) Cash BurnApril 25, 2024 | prnewswire.comCompugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024April 15, 2024 | stocknews.com3 Biotech Stocks with Potential Gains - Watch or Buy?April 14, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Sees Significant Increase in Short InterestCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 2,090,000 shares, a growth of 11.8% from the March 15th total of 1,870,000 shares. Based on an average daily volume of 651,500 shares, the short-interest ratio is currently 3.2 days.April 11, 2024 | investing.comCompugen reports progress on cancer therapy COM503April 10, 2024 | prnewswire.comCompugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503April 3, 2024 | finance.yahoo.comCompugen to Participate in Two Upcoming Investor ConferencesApril 2, 2024 | finance.yahoo.comIs Compugen Ltd. (NASDAQ:CGEN) Trading At A 31% Discount?March 19, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Short Interest Down 9.4% in FebruaryCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 29th, there was short interest totalling 1,830,000 shares, a decrease of 9.4% from the February 14th total of 2,020,000 shares. Based on an average trading volume of 2,800,000 shares, the days-to-cover ratio is presently 0.7 days.March 16, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Compugen (CGEN)March 11, 2024 | finance.yahoo.comCompugen Selected for two Oral Presentations at the Keystone Symposium on Cancer ImmunotherapyMarch 8, 2024 | seekingalpha.comCompugen Ltd. (CGEN) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | markets.businessinsider.comBuy Rating Justified by Compugen’s Positive Clinical Outlook and Financial StabilityMarch 7, 2024 | finance.yahoo.comCompugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Reports Fourth Quarter and Full Year 2023 ResultsMarch 6, 2024 | prnewswire.comCompugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024March 5, 2024 | msn.comCGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023March 5, 2024 | sfgate.comCompugen: Q4 Earnings SnapshotMarch 5, 2024 | prnewswire.comCompugen Reports Fourth Quarter and Full Year 2023 ResultsMarch 4, 2024 | benzinga.comEarnings Preview For CompugenFebruary 27, 2024 | marketbeat.comCompugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving Average of $1.29Compugen (NASDAQ:CGEN) Share Price Passes Above 200-Day Moving Average of $1.29February 26, 2024 | finance.yahoo.comCompugen to Present at the Leerink Partners Global Biopharma Conference 2024February 26, 2024 | prnewswire.comCompugen to Present at the Leerink Partners Global Biopharma Conference 2024February 22, 2024 | benzinga.comCompugen Stock (NASDAQ:CGEN), Short Interest ReportFebruary 22, 2024 | benzinga.comCompugen Stock (NASDAQ:CGEN) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comCompugen (CGEN) is a Great Momentum Stock: Should You Buy?February 20, 2024 | finance.yahoo.comCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024February 20, 2024 | prnewswire.comCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024February 16, 2024 | finance.yahoo.comCGEN Mar 2024 7.500 callFebruary 16, 2024 | finance.yahoo.comCGEN Mar 2024 1.500 putFebruary 15, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical OfficerFebruary 15, 2024 | finance.yahoo.comCompugen Announces Appointment of Michelle Mahler M.D. as Chief Medical OfficerFebruary 15, 2024 | prnewswire.comCompugen Announces Appointment of Michelle Mahler M.D. as Chief Medical OfficerFebruary 9, 2024 | marketbeat.comCompugen (NASDAQ:CGEN) Stock Passes Above Two Hundred Day Moving Average of $1.18Compugen (NASDAQ:CGEN) Shares Cross Above 200-Day Moving Average of $1.18January 28, 2024 | marketbeat.comCompugen Ltd. (NASDAQ:CGEN) Short Interest Down 24.5% in JanuaryCompugen Ltd. (NASDAQ:CGEN - Get Free Report) was the target of a large drop in short interest in January. As of January 15th, there was short interest totalling 1,600,000 shares, a drop of 24.5% from the December 31st total of 2,120,000 shares. Based on an average daily volume of 2,470,000 shares, the short-interest ratio is currently 0.6 days. Approximately 1.9% of the shares of the stock are short sold.January 13, 2024 | marketbeat.comShort Interest in Compugen Ltd. (NASDAQ:CGEN) Rises By 45.2%Compugen Ltd. (NASDAQ:CGEN - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 2,120,000 shares, an increase of 45.2% from the December 15th total of 1,460,000 shares. Based on an average daily trading volume, of 2,410,000 shares, the short-interest ratio is currently 0.9 days. Currently, 2.5% of the shares of the stock are sold short.January 8, 2024 | finanznachrichten.deCompugen Ltd.: Compugen Regains Compliance with Nasdaq Minimum Bid Price RequirementJanuary 5, 2024 | marketbeat.comCompugen (NASDAQ:CGEN) Lowered to "Sell" at StockNews.comStockNews.com lowered shares of Compugen from a "hold" rating to a "sell" rating in a report on Friday.December 26, 2023 | stocknews.comTop 4 Biotech Stock Buys for 2024 Gains Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide CGEN Media Mentions By Week CGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEN News Sentiment▼0.250.42▲Average Medical News Sentiment CGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEN Articles This Week▼81▲CGEN Articles Average Week Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Elevation Oncology News Opthea News X4 Pharmaceuticals News Zura Bio News Acumen Pharmaceuticals News INmune Bio News Genfit News Kodiak Sciences News Cellectis News Innate Pharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
